Talia Miller

541 total citations
19 papers, 435 citations indexed

About

Talia Miller is a scholar working on Oncology, Genetics and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Talia Miller has authored 19 papers receiving a total of 435 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 5 papers in Genetics and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Talia Miller's work include Acute Myeloid Leukemia Research (4 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (4 papers) and Advanced Breast Cancer Therapies (3 papers). Talia Miller is often cited by papers focused on Acute Myeloid Leukemia Research (4 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (4 papers) and Advanced Breast Cancer Therapies (3 papers). Talia Miller collaborates with scholars based in United States, Sweden and Australia. Talia Miller's co-authors include J J Dunn, Benjamin M. Wu, Weiwei Huang, Yu‐Fen Chou, Gregory T. Wolf, Carol R. Bradford, Graham P. Lidgard, Marc D. Meneghini, Lee Anne Beausang and F. Worden and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Biomaterials.

In The Last Decade

Talia Miller

17 papers receiving 428 citations

Peers

Talia Miller
V. Salih United Kingdom
Yun Su China
Abdullah C. Akman Türkiye
Zhangfan Ding China
Hadar Zigdon‐Giladi Israel
Ming Lin China
Wangsiyuan Teng China
Fabian Duttenhoefer Germany
Seung‐Ki Min South Korea
Linlin Xiao China
V. Salih United Kingdom
Talia Miller
Citations per year, relative to Talia Miller Talia Miller (= 1×) peers V. Salih

Countries citing papers authored by Talia Miller

Since Specialization
Citations

This map shows the geographic impact of Talia Miller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Talia Miller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Talia Miller more than expected).

Fields of papers citing papers by Talia Miller

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Talia Miller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Talia Miller. The network helps show where Talia Miller may publish in the future.

Co-authorship network of co-authors of Talia Miller

This figure shows the co-authorship network connecting the top 25 collaborators of Talia Miller. A scholar is included among the top collaborators of Talia Miller based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Talia Miller. Talia Miller is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
2.
Mukherjee, Sudipto, Kristin M. Zimmerman Savill, Ajeet Gajra, et al.. (2022). Real-world erythropoiesis-stimulating agent (ESA) treatment patterns and outcomes among U.S. patients with lower-risk myelodysplastic syndromes (LR-MDS).. Journal of Clinical Oncology. 40(16_suppl). e19065–e19065. 2 indexed citations
3.
4.
Savill, Kristin M. Zimmerman, et al.. (2021). Lower-Risk Myelodysplastic Syndromes: Erythropoiesis-Stimulating Agent Treatment Approaches and Outcomes in the United States. Blood. 138(Supplement 1). 4657–4657. 3 indexed citations
5.
Kish, Jonathan, Talia Miller, Xianchen Liu, et al.. (2020). Abstract P5-14-13: Real-world dosing and CBC monitoring in patients with metastatic breast cancer during palbociclib plus letrozole therapy. Cancer Research. 80(4_Supplement). P5–14.
6.
Kish, Jonathan, Bela Bapat, Ajeet Gajra, et al.. (2020). Real-world outcomes of pembrolizumab plus carboplatin plus paclitaxel or nab-paclitaxel in non-small cell lung cancer (NSCLC).. Journal of Clinical Oncology. 38(15_suppl). e21717–e21717. 3 indexed citations
7.
8.
Gerds, Aaron T., et al.. (2020). Real-world disease burden for patients (pts) with myelofibrosis (MF) treated with ruxolitinib (RUX).. Journal of Clinical Oncology. 38(15_suppl). e19539–e19539. 3 indexed citations
9.
Kish, Jonathan, et al.. (2019). Real-world effectiveness of first-line palbociclib + letrozole for metastatic breast cancer 4 years post approval in the US. Annals of Oncology. 30. v120–v121. 2 indexed citations
10.
Mougalian, Sarah S., Bruce A. Feinberg, Wenge Wang, et al.. (2019). Observational Study of Clinical Outcomes of Eribulin Mesylate in Metastatic Breast Cancer After Cyclin-Dependent Kinase 4/6 Inhibitor Therapy. Future Oncology. 15(34). 3935–3944. 11 indexed citations
11.
Miller, Talia, et al.. (2017). Differences in Efficacy Between Gamithromycin, Tilmicosin, and Tulathromycin as Metaphylactic Treatments in High Risk Calves for Bovine Respiratory Disease. Kansas Agricultural Experiment Station Research Reports. 3(1). 1 indexed citations
12.
Weitman, Evan, Matthew Perez, John F. Thompson, et al.. (2017). Quality of life patient-reported outcomes for locally advanced cutaneous melanoma. Melanoma Research. 28(2). 134–142. 14 indexed citations
13.
Gandhi, Dheeraj, Douglas B. Chepeha, Talia Miller, et al.. (2006). Correlation between initial and early follow-up CT perfusion parameters with endoscopic tumor response in patients with advanced squamous cell carcinomas of the oropharynx treated with organ-preservation therapy.. PubMed. 27(1). 101–6. 96 indexed citations
14.
Carey, Thomas E., Jean B. deKernion, Robert Dreicer, et al.. (2005). Bridging the gap: Health disparity research initiatives through the department of defense (DOD) congressionally directed medical research programs (CDMRP) prostate cancer research program (PCRP). Cancer Research. 65. 599–599. 4 indexed citations
15.
Miller, Talia, Randy Schneider, Joan W. Miller, et al.. (2005). Photoreceptor cell apoptosis induced by the 2-nitroimidazole radiosensitizer, CI-1010, is mediated by p53-linked activation of caspase-3. NeuroToxicology. 27(1). 44–59. 12 indexed citations
16.
Chou, Yu‐Fen, Weiwei Huang, J J Dunn, Talia Miller, & Benjamin M. Wu. (2004). The effect of biomimetic apatite structure on osteoblast viability, proliferation, and gene expression. Biomaterials. 26(3). 285–295. 197 indexed citations
17.
Miller, Talia, Scott Williams, Regina Gandour‐Edwards, et al.. (1999). Response to a taxol based chemotherapy regimen in advanced transitional cell carcinoma is independent of p53 expression. 47(2). 3 indexed citations
18.
Jones, J. Wayne, Theodore F. Beals, M J Worsham, et al.. (1997). Frequent Loss of Heterozygosity on Chromosome Arm 18q in Squamous Cell Carcinomas: Identification of 2 Regions of Loss--18q11.1-q12.3 and 18q21.1-q23. Archives of Otolaryngology - Head and Neck Surgery. 123(6). 610–614. 40 indexed citations
19.
Miller, Talia, Lee Anne Beausang, Marc D. Meneghini, & Graham P. Lidgard. (1993). Death-induced changes to the nuclear matrix: the use of anti-nuclear matrix antibodies to study agents of apoptosis.. PubMed. 15(6). 1042–7. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by V. Salih Breakdown of academic impact, for papers by Yun Su Breakdown of academic impact, for papers by Abdullah C. Akman Breakdown of academic impact, for papers by Zhangfan Ding Breakdown of academic impact, for papers by Hadar Zigdon‐Giladi Breakdown of academic impact, for papers by Ming Lin Breakdown of academic impact, for papers by Wangsiyuan Teng Breakdown of academic impact, for papers by Fabian Duttenhoefer Breakdown of academic impact, for papers by Seung‐Ki Min Breakdown of academic impact, for papers by Linlin Xiao
Rankless by CCL
2026